Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki Brower

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
The Lancet. Oncology|August 30, 2007
Predicting response to cisplatin in NSCLCVicki Brower
Nature|January 9, 2009
European boost for particle therapyVicki Brower
Journal of the National Cancer Institute|September 25, 2008
ESAs further restricted, but debate continuesVicki Brower
The Lancet. Oncology|December 22, 2015
Venetoclax targets BCL2 in chronic lymphocytic leukaemiaVicki Brower
Journal of the National Cancer Institute|August 6, 2015
American Association of Cancer Research Showcases Immunotherapy AdvancesVicki Brower
Journal of the National Cancer Institute|April 3, 2016
Adhesion Molecules, Stem Cells, and the Microenvironment in Acute Myeloid LeukemiaVicki Brower
The Lancet. Oncology|October 3, 2017
Adding radiotherapy to chemotherapy in advanced NSCLCVicki Brower
Journal of the National Cancer Institute|December 15, 2015
Targeted Therapies Improve Outlook for Chronic Lymphocytic LeukemiaVicki Brower
The Lancet. Oncology|May 31, 2016
Capecitabine and lapatinib treatment in head and neck cancerVicki Brower
The Lancet. Oncology|June 14, 2016
Physical frailty in survivors of haemopoietic cell transplantVicki Brower
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
The Lancet. Oncology|August 30, 2007
Predicting response to cisplatin in NSCLCVicki Brower
Nature|January 9, 2009
European boost for particle therapyVicki Brower
Journal of the National Cancer Institute|September 25, 2008
ESAs further restricted, but debate continuesVicki Brower
The Lancet. Oncology|December 22, 2015
Venetoclax targets BCL2 in chronic lymphocytic leukaemiaVicki Brower
Journal of the National Cancer Institute|August 6, 2015
American Association of Cancer Research Showcases Immunotherapy AdvancesVicki Brower
Journal of the National Cancer Institute|April 3, 2016
Adhesion Molecules, Stem Cells, and the Microenvironment in Acute Myeloid LeukemiaVicki Brower
The Lancet. Oncology|October 3, 2017
Adding radiotherapy to chemotherapy in advanced NSCLCVicki Brower
Journal of the National Cancer Institute|December 15, 2015
Targeted Therapies Improve Outlook for Chronic Lymphocytic LeukemiaVicki Brower
The Lancet. Oncology|May 31, 2016
Capecitabine and lapatinib treatment in head and neck cancerVicki Brower
The Lancet. Oncology|June 14, 2016
Physical frailty in survivors of haemopoietic cell transplantVicki Brower
Pageof 18